| Literature DB >> 24288363 |
M Crisby1, L Henareh2, Stefan Agewall3.
Abstract
We determined whether plasma levels of circulating oxidized low-density lipoprotein (LDL; E06), immunoglobulin (Ig) G, and IgM autoantibodies binding to malonyldialdehyde-modified LDL (MDA-LDL) may predict cardiovascular events (CVEs). Patients (n=123) with a previous myocardial infarction (MI) were included. The primary end point was defined as any of the following: cardiovascular death from any cause, nonfatal reinfarction or stroke, percutaneous coronary intervention, coronary artery bypass grafting, and hospitalization due to angina pectoris. There were 43 CVEs during the follow-up period of 8.4±3.5 years. There was no significant difference in the levels of E06 and MDA-LDL IgG between the CVE and the event-free group. However, MDA-LDL IgM levels were significantly lower in patients in the CVE group (9524±6326 relative light unit [RLU]) compared with the event-free (10,975±5398 RLU) group (P=.04). In conclusion, levels of MDA-LDL IgM were associated with an increased risk of CVE in patients with a previous MI.Entities:
Keywords: IgM and IgG MDA-LDL autoantibodies; biomarkers; cardiovascular events; myocardial infarction; oxidized LDL
Mesh:
Substances:
Year: 2013 PMID: 24288363 DOI: 10.1177/0003319713512720
Source DB: PubMed Journal: Angiology ISSN: 0003-3197 Impact factor: 3.619